Cervical Cancer Screening
Reimagined for the Caribbean
CellSolutions delivers the complete cytology workflow from specimen preservation to AI-powered digital screening with remote diagnosis — closing the screening gap across 33 Caribbean territories where cytotechnologist access is limited.
The only end-to-end liquid-based cytology and digital pathology solution available in the Caribbean. From small island clinics to national reference laboratories.
Why the Caribbean Needs Better Cervical Cancer Screening
Cervical cancer is preventable and curable when detected early. But screening rates across the Caribbean remain critically low, and the infrastructure gap widens every year.
The Burden
Cervical cancer is the second most common cancer among Caribbean women. Age-standardized incidence rates in the Caribbean (14.1 per 100,000) exceed the global average. Many islands have no organized screening programs.
The Screening Gap
WHO targets screening 70% of women aged 30–49 by 2030. Most Caribbean nations screen fewer than 30%. Limited cytotechnologist availability, outdated Pap smear methods, and sample transport challenges contribute to the gap.
Cytotechnologist Shortage
Many Caribbean islands have zero resident cytotechnologists or cytopathologists. Slides are shipped abroad for reading, adding weeks to turnaround time and increasing the risk of patient loss to follow-up.
HPV Prevalence
HPV prevalence among Caribbean women ranges from 20–35% depending on the island. Combined with limited screening infrastructure, this drives higher rates of late-stage cervical cancer diagnosis.
WHO Elimination Strategy
WHO’s Global Strategy to Accelerate the Elimination of Cervical Cancer calls for 90% HPV vaccination, 70% screening coverage, and 90% treatment of pre-cancers. PAHO supports Caribbean implementation.
PAHO Regional Commitment
PAHO’s Plan of Action for Cervical Cancer Prevention specifically targets Caribbean and Latin American countries with grants, technical assistance, and procurement support for screening infrastructure.
Caribbean Diagnostics is the exclusive distributor of CellSolutions products across all Caribbean territories. ISO 13485:2016 certified. Founded by the pioneer of liquid-based cytology automation.
The CellSolutions Advantage
An end-to-end cytology platform that scales from a single island clinic to a national screening network with AI-powered digital pathology.
Tiered for Every Lab Size
GluCyte manual method for small clinics (25–30 slides/hr, no capital equipment). CellSolutions 30 for mid-volume labs (30 slides/hr automated). CellSolutions F50 for high-throughput reference labs (1 slide/min).
Superior Specimen Quality
BestPrep preservative: 100% HSIL sensitivity vs ThinPrep 95.6% in a double-blind study. 1.2% unsatisfactory rate (GluCyte) vs 4.8% (ThinPrep). Non-flammable — safe for Caribbean air freight.
AI-Powered Digital Screening
BestCyte scans slides 24/7, detects and classifies abnormal cells using advanced algorithms, and presents sorted galleries for efficient review. Primary screening in 1.4 minutes vs 4.8 min (CLIA standard).
Remote Diagnosis
BestCyte’s web-based software enables cytopathologists to screen and diagnose cases from any location. A pathologist in Miami reads slides scanned in Nassau, Grand Cayman, or Bridgetown — same day.
HPV Co-Testing Compatible
BestPrep General Cytology Preservative is compatible with DNA-based HPV testing and infectious disease panels. One specimen collection for both cytology and molecular testing.
Caribbean-Ready Logistics
Non-flammable preservative ships without hazmat restrictions. Ambient temperature transport for preserved specimens. Caribbean Diagnostics provides in-territory installation, training, and ongoing reagent supply.
CellSolutions vs. Hologic & BD
How the CellSolutions platform compares to the incumbent ThinPrep and SurePath systems on the metrics that matter most for Caribbean deployment.
| Metric | CellSolutionsBestPrep + BestCyte | Hologic ThinPrepImaging System | BD SurePathFocalPoint GS |
|---|---|---|---|
| HSIL Sensitivity | 100% | 95.6% | ~95% |
| Unsatisfactory Rate | 1.2% | 4.8% | <1% |
| Primary Screening Time | 1.4 min | ~5 min | ~5 min |
| Remote Web Diagnosis | Yes | No | No |
| AI Cell Sorting | 8 galleries | 22 FOVs | Slide ranking |
| Preservative Flammability | Non-flammable | Flammable (methanol) | Formaldehyde-based |
| Capital Entry Point | GluCyte (no instrument) | T5000 processor | PrepStain |
| HPV Co-Testing | Yes | Yes | Yes |
Complete Cytology Portfolio
From specimen collection to AI-powered digital diagnosis. Three tiers of slide preparation for every lab volume. One integrated digital screening platform.
BestPrep General Cytology Preservative
PreservationNon-flammable, less toxic preservative for all cytology specimens. Maintains cellular morphology, tolerates blood without inhibiting diagnosis. Compatible with DNA-based HPV and infectious disease testing. Outperforms ThinPrep PreservCyt in HSIL detection (100% vs 95.6%).
- Non-flammable (safe for air freight)
- HPV and molecular testing compatible
- 100% HSIL sensitivity (double-blind study)
- Available in 1L bottles and pre-filled vials
GluCyte Manual Method
Preparation — Low VolumeCost-effective slide preparation for clinics and small labs. No expensive capital equipment required. Centrifugation-based cell concentration with consistent thin-layer presentation. 500-test kits include all reagents and disposables.
- 25–30 slides per hour
- No capital equipment needed
- 1.2% unsatisfactory rate
- 500-test consumable kits
CellSolutions 30
Preparation — Mid VolumeWalk-away automated processor for labs processing up to 60,000 slides/year. Automated custom dilution, consistent cellularity, barcode tracking. Compatible with standard staining cassettes.
- 30 slides per hour automated
- Up to 60,000 slides/year
- Barcode sample tracking
- Walk-away automation
CellSolutions F50
Preparation — High ThroughputSecond-generation dual filter technology for high-volume reference labs. Patented filtration system with adjustable cycles for different sample types. Enhanced cellular enrichment reduces obscuring from blood, inflammation, and mucus.
- 1 sample every 60 seconds
- Patented dual filter technology
- Enhanced cellular enrichment
- Adjustable processing cycles
BestCyte Digital Cytology System
AI Screening & Remote DiagnosisFully automated glass slide scanner with AI-powered cell detection and classification. Scans thin-layer cytology slides 24/7, presents abnormal cells in 8 sorted galleries at up to 40x magnification. Web-based software enables secure remote screening from any location.
- 24/7 automated scanning
- AI cell detection and sorting
- Web-based remote diagnosis
- 96.6% primary diagnosis concordance
Red Lytic Preservative
Preservation — Non-GynecologicalSpecialized preservative for non-gynecological cytology specimens including FNA, urine, body fluids, and respiratory samples. Greatly reduces interference from blood and mucus for cleaner thin-layer preparations.
- Non-gyn specimen optimization
- Blood and mucus lysis
- Compatible with thin-layer prep
- Available in vials and bulk
Caribbean Cytology Network
A distributed screening model that brings gold-standard digital cytology to every island, with centralized expert review.
Specimen Collection
Clinic collects cervical sample into BestPrep preservative vial. Ships ambient to nearest processing lab.
Slide Preparation
Processing lab prepares thin-layer slide using GluCyte, CS-30, or F50 based on volume.
Digital Scanning
BestCyte scanner digitizes slide at high resolution. AI algorithms detect and classify cells.
Remote Diagnosis
Cytopathologist reviews AI-sorted cell galleries via web browser from any location. Same-day results.
BestCyte enables centralized digital pathology review across multiple islands from a single hub.
Ministry of Health & PAHO Procurement
Caribbean Diagnostics supports national cervical cancer screening programs with island-wide deployment, training, and sustainable reagent supply.
For Ministries of Health
- National screening program pricing for all Caribbean territories
- WHO/PAHO-aligned procurement documentation
- Tiered deployment: GluCyte for clinics, CS-30 for hospitals, F50 for reference labs
- BestCyte digital hub for centralized remote cytopathology
- In-territory installation, validation, and operator training
- Sustainable reagent supply chain with regional buffer stock
- HPV co-testing workflow integration
- Quality assurance and proficiency testing support
Target Institutions
Ready to Transform Cervical Cancer Screening?
Contact Caribbean Diagnostics for Ministry of Health program pricing, PAHO procurement support, and technology evaluation. We deploy across all 33 Caribbean territories.